Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
Health
Julia Musto

THE TRUTH ABOUT: Fda asks drugmaker eli lilly for more safety information on its new glp 1 weight loss pill - The Untold Story

A GLP-1 weight loss pill, already on sale in the United States, has hit a regulatory snag.

The Food and Drug Administration has asked U.S. drugmaker Eli Lilly to collect more long-term safety data on its once-daily tablet Foundayo, according to an April 1 letter published by the FDA Tuesday.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.